Abstract:Bluetongue virus (BTV) is an agriculturally and economically significant insect-borne virus that causes serious illness and death in sheep and other domestic and wild ruminants in large areas of the world. Numerous BTV serotypes exist, and distant serotypes exhibit unique neutralizing antibody profiles, which target the outermost capsid protein VP2. The predominant serotype-specific nature of the antibody response to VP2 is a barrier to the development of broad-spectrum prophylactic BTV vaccine candidates. Although VP2 is the main serotype determinant of BTV, the structural basis of serotype specificity has not been investigated. In this study, we utilized the recently available atomic structure of VP2 with a modeled tip domain to carry out in silico structural comparisons between distant serotypes BTV1 and BTV8. These analyses identified structural differences in the tip domain, positioned at the apex of VP2, and informed the design of mutant VP2 constructs. Dissection of tip domain antigenicity demonstrated that the region of structural difference between BTV1 and highly virulent BTV8 was a target of BTV neutralizing antibodies and that mutation of this region resulted in a loss of neutralizing antibody recognition. This study has for the first time provided insights into the structural differences, which underpin the serotype-specific neutralizing antibody response to BTV.IMPORTANCEThe immune system can protect against virus infection by producing antibodies, which bind and inhibit the virus from infecting the susceptible host. These antibodies are termed neutralizing antibodies and generally target the viral receptor binding protein, such as the VP2 of bluetongue virus (BTV). This pressure from the immune system can drive mutation of the viral protein resulting in escape from antibody-mediated neutralization and the evolution of serotypes, as is the case for BTV. Understanding the structural differences, which underpin the different BTV serotypes, could help guide the design of a BTV vaccine that targets multiple serotypes. In this study, we have mapped the VP2 structural differences between distant serotypes, to a region targeted by neutralizing antibodies, and have demonstrated for the first time how VP2 structure is the fundamental basis of serotype specificity.

Identification of the epitopes recognized by a monoclonal antibody against VP2 protein of bluetongue virus serotype 4

Identification of Antigenic Epitopes of Monoclonal Antibodies Against the VP2 Protein of the 25 Serotype of Bluetongue Virus.

[Identification of Epitope Recognized by a Monoclonal Antibody Against VP2 Protein of Bluetongue Virus Serotype 8].

Identification of a novel bluetongue virus 1 specific B cell epitope using monoclonal antibodies against the VP2 protein

Identification of Four Novel Group-Specific Bluetongue Virus Ns3 Protein B-Cell Epitopes

Analysis of Murine B-cell Epitopes on Bluetongue Virus 12 Nonstructural Protein 1.

Expression and Immunogenic Comparison of VP2 and VP3 from Marine Birnavirus

Identification of a linear B-cell epitope on the "puff" loop of the Senecavirus A VP2 protein involved in receptor binding

Screening and Identification of Efficient T and B Combined Epitopes of Vibrio vulnificus Hemolysin Based on Phage Display Technique

The Epitope Recognized by Monoclonal Antibody 2B6 in the B/C Domains of Classical Swine Fever Virus Glycoprotein E2 Affects Viral Binding to Hyperimmune Sera and Replication.

Identification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies

Computational identification of epitopes in the glycoproteins of novel bunyavirus (SFTS virus) recognized by a human monoclonal antibody (MAb 4-5)

Identification of a Conserved B-Cell Epitope on the Capsid Protein of Porcine Circovirus Type 4

Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping.

Soluble Expression, Purification and Characterization of the VP3 of the 1st Serotype Bluetongue Virus

Identification of a Novel Aleutian Mink Disease Virus B-cell Epitope Using a Monoclonal Antibody Against VP2 Protein

Impact of VP2 structure on antigenicity: comparison of BTV1 and the highly virulent BTV8 serotype

The Identification of a B-cell Epitope in Bovine Viral Diarrhea Virus (BVDV) Core Protein Based on a Mimotope Obtained from a Phage-Displayed Peptide Library

Identification of linear B-cell epitopes on the phosphoprotein of Canine distemper virus using four monoclonal antibodies.

Soluble Expression and Purification of Bluetongue Virus Type 1 (BTV1) Structure Protein VP2 in Escherichia Coli and Its Immunogenicity in Mice

Frozen motion of gliding bacteria outlines inherent features of the motility apparatus.